Optic Neuropathy Management Global Market Report 2025
상품코드:1826960
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
시신경병증 관리 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 36억 2,000만 달러, 2025년에는 38억 3,000만 달러에 달하고, CAGR 5.9%로 성장할 전망입니다. 역사적인 기간의 성장은 시신경 장애의 유병률 증가, 눈 외상 증가, 안과 의료 서비스 투자 증가, 전문 안과 의료 서비스 수요 증가, 당뇨병 이환율 증가 및 기타 만성 질환으로 인한 것입니다.
시신경병증 관리 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.8%로 48억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 아메바 감염에 걸린 사람 증가, 노년 인구 증가, 시신경염의 유병률 증가, 녹내장의 이환율 증가, 시신경염의 유병률 증가에 기인합니다. 예측기간의 주요 동향으로는 의료기술의 진보, 개별화의료와 원격의료, 진단기술의 기술진보, 신흥 시장에서의 헬스케어 인프라의 확대, 신경보호요법에 대한 주목 등을 들 수 있습니다.
시신경병증 관리는 시신경 장애의 진단, 치료 및 모니터링에 관여하고 약물 치료, 생활 습관 개선, 수술 개입, 시력 재활을 통해 추가 악화를 방지하고 시력을 향상시킵니다.
시신경병증 관리의 주요 치료법에는 약물 요법, 수술 요법 및 기타 치료법이 있습니다. 약물 요법은 염증을 억제하거나 신경 기능을 보호하는 등 신체 기능을 변화시킴으로써 질병의 치료, 관리, 예방에 사용됩니다. 진단에는 일반적으로 이미지 검사, 혈액 검사 및 기타 진단 절차가 포함됩니다. 치료는 병원, 전문 클리닉, 외래수술센터(ASC) 및 기타 의료시설과 같은 다양한 건강 관리 환경에서 수행됩니다.
2025년 봄 미국 관세의 급상승과 이에 따른 무역 마찰은 의료 부문, 특히 필수 의료기기, 진단 장비 및 의약품 공급에 큰 영향을 미쳤습니다. 병원과 건강 관리 제공업체는 수입되는 수술 기구, 영상 진단 시스템, 주사기 및 카테터와 같은 소모품의 비용 상승에 시달리고 있으며, 그 대부분은 국내 대체품이 제한되어 있습니다. 이러한 비용 상승이 의료 예산을 압박하기 때문에 일부 의료기관은 장비 업그레이드를 늦추거나 비용 증가를 환자에게 전가하고 있습니다. 게다가 원료와 부품에 대한 관세는 중요한 의약품과 의료기기의 제조에 지장을 주고 공급망의 지연으로 이어지고 있습니다. 이에 비해 업계는 다양한 조달 전략을 채택하고 가능한 한 현지 생산을 확대하고 중요한 의료 제품의 관세 면제를 수행하고 있습니다.
이 조사 보고서는 시신경병증 관리 업계 세계 시장 규모, 지역 점유율, 시신경병증 관리 시장 점유율을 가진 경쟁 업체, 상세한 시신경병증 관리 시장 부문, 시장 동향, 비즈니스 기회 등 시신경병증 관리 시장 통계를 제공하는 The Business Research Company의 신간 보고서 시리즈 중 하나입니다. 이 시신경병증 관리 시장 조사 보고서는 업계의 현재 및 미래 시나리오를 자세히 분석하고 필요한 모든 것을 완벽한 관점에서 제공합니다.
향후 5년간의 성장률 5.8%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 스위스와 벨기에에서 개발된 바이러스 벡터 기반 치료제의 가격을 상승시키고, 치료되지 않은 환자의 시력 저하를 진행시키고, 희귀질환 치료비의 상승을 초래함으로써, 유전성 시신경증에 대한 유전자 치료의 미국 채택을 방해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
안 질환의 유병률 증가는 앞으로 수년간 시신경병증 관리 시장의 성장을 이끌 것으로 예측됩니다. 눈 질환에는 눈의 구조와 기능에 영향을 미치고 시력 장애와 관련 증상을 일으키는 모든 질병이 포함됩니다. 이러한 증상 증가는 인구 고령화, 장기간 스크린 노출, 건강에 해로운 라이프 스타일 선택, 당뇨병과 같은 기본 건강 문제 등의 요인에 의해 영향을 받습니다. 시신경병증 관리는 시신경의 추가 손상을 방지하고 시력을 유지함으로써 눈 질환의 영향을 줄이는 데 중요한 역할을 합니다. 예를 들어, 2025년 2월 영국 정부 기관인 보건사회복지성은 영국에서는 약 200만명이 어느 정도의 시력 저하를 갖고 생활하고 있다고 보고하고, 2030년까지 270만명으로 증가할 것으로 예측했습니다. 그 결과, 안 질환의 유병률 증가가 시신경병증 관리 시장의 확대에 박차를 가하고 있습니다.
시신경병증 관리 시장의 주요 기업은 경쟁 우위를 확보하기 위해 단일클론항체 치료와 같은 혁신적인 치료에 주력하고 있습니다. 단일클론항체는 바이러스 및 박테리아와 같은 유해한 병원체와 싸우는 면역계의 능력을 모방하도록 설계된 실험실에서 설계된 단백질입니다. 예를 들어, 2023년 3월, 아일랜드에 본사를 두고 있는 Horizon Therapeutics사는 이 회사의 의약품인 아플리즈나(Inevilizumab)의 MRI 소견에 대한 새로운 분석을 발표했습니다. 이 연구는 아플리즈나가 시신경 척수염 스펙트럼 장애(NMOSD) 환자의 무증상 시신경 병변의 형성을 억제하는 것으로 나타났습니다. 이 결과는 Horizon이 시신경 척수염 스펙트럼 장애, 통풍, 갑상선 안과 같은 희귀질환에 대한 고급 치료법을 개발하기 위해 노력하고 있음을 보여줍니다. 아플리즈나는 유해한 B 세포를 표적으로 제거하도록 설계된 단일클론항체로 염증을 억제하고 중추신경계와 시신경의 추가 손상을 방지하고 결국 재발을 예방하고 시력을 유지하는 데 도움이 됩니다.
2024년 1월 미국 생명과학기업인 나야 바이오사이언시스는 플로리다 바이오테크놀러지스를 2,000만 달러로 인수했습니다. 이 인수에는 시력 저하를 일으키는 드문 유전성 질환인 리버 유전성 시신경증(LHON)의 치료를 목적으로 하는 유전자 치료 프로그램이 포함되어 있습니다. Florida Biotechnologies는 미국에 본사를 둔 유전자 치료 회사로 LHON을 포함한 미토콘드리아 병의 치료를 전문으로합니다.
시신경병증 관리 시장은 항염증 치료, 대사 및 영양 지원, 유전자 및 줄기세포 치료 등의 서비스를 제공하는 사업체가 얻는 수익으로 구성됩니다. 시장 가치에는 서비스 제공업체가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 시신경병증 관리 시장에는 신경 보호 요법, 고급 이미지 솔루션, AI 주도 진단 도구의 판매가 포함됩니다. 이 시장의 가치는 "Factory Gate"의 가치, 즉 상품의 제조자 또는 제작자가 다른 기업(다운스트림 제조자, 도매업체, 유통업체, 소매업체 포함) 또는 직접 최종 고객에게 판매 한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품 제작자에 의해 판매되는 관련 서비스도 포함됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 시신경병증 관리 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 시신경병증 관리 시장 : 성장률 분석
세계의 시신경병증 관리 시장 실적 : 규모와 성장, 2019-2024
세계의 시신경병증 관리 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 시신경병증 관리 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 시신경병증 관리 시장 : 치료유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
의약품
수술
기타 치료
세계의 시신경병증 관리 시장 : 진단별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
영상 검사
혈액 검사
기타 진단
세계의 시신경병증 관리 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
외래수술센터(ASC)
기타 최종 사용자
세계의 시신경병증 관리 시장 : 세분화 의약품(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
Corticosteroids
신경보호제
항산화 물질
면역억제제
프로스타글란딘 유사체
세계의 시신경병증 관리 시장 : 세분화 수술유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
시신경 감압 수술
시신경 이식
망막 이식 수술
세계의 시신경병증 관리 시장 : 세분화 기타 치료법(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
저시력 보조구
줄기세포요법
유전자 치료
제7장 지역별/국가별 분석
세계의 시신경병증 관리 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 시신경병증 관리 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
시신경병증 관리 시장 : 경쟁 구도
시신경병증 관리 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Novartis AG
Eli Lilly and Company
Amgen Inc.
Merck KGaA
Teva Pharmaceuticals
Otsuka Pharmaceutical Co. Ltd.
Regeneron Pharmaceuticals Inc.
Bausch Health Companies Inc.
Alexion Pharmaceuticals Inc.
Horizon Therapeutics plc
Santen Pharmaceutical Co. Ltd.
Mallinckrodt Pharmaceuticals
Aerie Pharmaceuticals
Neurophth Therapeutics
AdvaCare
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
시신경병증 관리 시장 2029 : 새로운 기회를 제공하는 국가
시신경병증 관리 시장 2029 : 새로운 기회를 제공하는 부문
시신경병증 관리 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Optic neuropathy management involves the diagnosis, treatment, and monitoring of optic nerve damage through medications, lifestyle modifications, surgical interventions, and vision rehabilitation to prevent further deterioration and improve visual function.
The primary treatment types for optic neuropathy management include medications, surgery, and other therapeutic approaches. Medications are used to treat, manage, or prevent diseases by altering bodily functions, such as reducing inflammation or protecting nerve function. Diagnosis typically involves imaging tests, blood tests, and other diagnostic procedures. Treatment is provided across various healthcare settings, including hospitals, specialty clinics, ambulatory surgical centers, and other medical facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The optic neuropathy management market research report is one of a series of new reports from The Business Research Company that provides optic neuropathy management market statistics, including the optic neuropathy management industry global market size, regional shares, competitors with the optic neuropathy management market share, detailed optic neuropathy management market segments, market trends, and opportunities, and any further data you may need to thrive in the optic neuropathy management industry. This optic neuropathy management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The optic neuropathy management market size has grown strongly in recent years. It will grow from $3.62 billion in 2024 to $3.83 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising prevalence of optic neuropathy, the rising number of eye injuries, the increase in their investment in eye care services, the increasing demand for specialized eye care services, the rising incidence of diabetes, and other chronic diseases.
The optic neuropathy management market size is expected to see strong growth in the next few years. It will grow to $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the growing number of individuals afflicted by amebic infections, increasing geriatric population, increasing prevalence of optic neuritis, growing incidence of glaucoma, and increased prevalence rate of optic neuritis. Major trends in the forecast period include advancements in medical technology, personalized medicine and telemedicine, technological advancements in diagnostic techniques, expansion of healthcare infrastructure in emerging markets, and a focus on neuroprotective therapies.
The forecast of 5.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of gene therapy for hereditary optic neuropathies by inflating prices of viral vector-based treatments developed in Switzerland and Belgium, resulting in progressive vision loss in untreated patients and higher rare disease therapy costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of eye diseases is expected to drive the growth of the optic neuropathy management market in the coming years. Eye disease encompasses any condition that affects the structure or function of the eyes, leading to vision impairment or related symptoms. The rising occurrence of these conditions is influenced by factors such as aging populations, prolonged screen exposure, unhealthy lifestyle choices, and underlying health issues such as diabetes. Optic neuropathy management plays a crucial role in reducing the impact of eye diseases by preventing further optic nerve damage and preserving vision. For instance, in February 2025, the Department of Health and Social Care, a UK-based government department, reported that approximately 2 million people in the UK were living with some degree of sight loss, with projections indicating an increase to 2.7 million by 2030. As a result, the growing prevalence of eye disease is fueling the expansion of the optic neuropathy management market.
Leading companies in the optic neuropathy management market are focusing on innovative therapies, such as monoclonal antibody treatments, to gain a competitive edge. Monoclonal antibodies are lab-engineered proteins designed to mimic the immune system's ability to fight harmful pathogens such as viruses and bacteria. For example, in March 2023, Horizon Therapeutics, an Ireland-based company, presented a new analysis of MRI findings for its drug, UPLIZNA (inebilizumab). The study revealed that UPLIZNA reduces the formation of asymptomatic optic nerve lesions in patients with neuromyelitis optica spectrum disorder (NMOSD). This underscores Horizon's dedication to developing advanced treatments for rare conditions such as NMOSD, gout, and thyroid eye disease. UPLIZNA is a monoclonal antibody designed to target and eliminate harmful B cells, reducing inflammation and preventing further damage to the central nervous system and optic nerves, ultimately helping to prevent relapses and preserve vision.
In January 2024, Naya Biosciences, a US-based life sciences company, acquired Florida Biotechnologies for $20 million. This acquisition includes a gene therapy program aimed at treating Leber's hereditary optic neuropathy (LHON), a rare genetic disorder that leads to vision loss. Florida Biotechnologies is a US-based gene therapy company specializing in treatments for mitochondrial diseases, including LHON.
Major players in the optic neuropathy management market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics plc, Santen Pharmaceutical Co. Ltd., Mallinckrodt Pharmaceuticals, Aerie Pharmaceuticals, Neurophth Therapeutics, and AdvaCare.
North America was the largest region in the optic neuropathy management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in optic neuropathy management report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the optic neuropathy management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The optic neuropathy management market consists of revenues earned by entities by providing services such as anti-inflammatory treatments, metabolic and nutritional support, and gene and stem cell therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The optic neuropathy management market includes sales of neuroprotective therapies, advanced imaging solutions, and AI-driven diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Optic Neuropathy Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on optic neuropathy management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for optic neuropathy management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The optic neuropathy management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Medications; Surgery; Other Treatment Types
2) By Diagnosis: Imaging Tests; Blood Tests; Other Diagnosis
3) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Medications: Corticosteroids; Neuroprotective Agents; Antioxidants; Immunosuppressants; Prostaglandin Analogs
2) By Surgery: Optic Nerve Decompression Surgery; Optic Nerve Transplantation; Retinal Implant Surgery
3) By Other Treatment Types: Low Vision Aids; Stem Cell Therapy; Gene Therapy
3. Optic Neuropathy Management Market Trends And Strategies
4. Optic Neuropathy Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Optic Neuropathy Management Growth Analysis And Strategic Analysis Framework
5.1. Global Optic Neuropathy Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Optic Neuropathy Management Market Growth Rate Analysis
5.4. Global Optic Neuropathy Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Optic Neuropathy Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Optic Neuropathy Management Total Addressable Market (TAM)
6.1. Global Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Surgery
Other Treatment Types
6.2. Global Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Tests
Blood Tests
Other Diagnosis
6.3. Global Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Other End-Users
6.4. Global Optic Neuropathy Management Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Neuroprotective Agents
Antioxidants
Immunosuppressants
Prostaglandin Analogs
6.5. Global Optic Neuropathy Management Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Optic Nerve Decompression Surgery
Optic Nerve Transplantation
Retinal Implant Surgery
6.6. Global Optic Neuropathy Management Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Low Vision Aids
Stem Cell Therapy
Gene Therapy
7. Optic Neuropathy Management Market Regional And Country Analysis
7.1. Global Optic Neuropathy Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Optic Neuropathy Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Optic Neuropathy Management Market
9.1. China Optic Neuropathy Management Market Overview
9.2. China Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Optic Neuropathy Management Market
10.1. India Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Optic Neuropathy Management Market
11.1. Japan Optic Neuropathy Management Market Overview
11.2. Japan Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Optic Neuropathy Management Market
12.1. Australia Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Optic Neuropathy Management Market
13.1. Indonesia Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Optic Neuropathy Management Market
14.1. South Korea Optic Neuropathy Management Market Overview
14.2. South Korea Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Optic Neuropathy Management Market
15.1. Western Europe Optic Neuropathy Management Market Overview
15.2. Western Europe Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Optic Neuropathy Management Market
16.1. UK Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Optic Neuropathy Management Market
17.1. Germany Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Optic Neuropathy Management Market
18.1. France Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Optic Neuropathy Management Market
19.1. Italy Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Optic Neuropathy Management Market
20.1. Spain Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Optic Neuropathy Management Market
21.1. Eastern Europe Optic Neuropathy Management Market Overview
21.2. Eastern Europe Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Optic Neuropathy Management Market
22.1. Russia Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Optic Neuropathy Management Market
23.1. North America Optic Neuropathy Management Market Overview
23.2. North America Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Optic Neuropathy Management Market
24.1. USA Optic Neuropathy Management Market Overview
24.2. USA Optic Neuropathy Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Optic Neuropathy Management Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Optic Neuropathy Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
